GlaxoSmithKline PLC

Advised to GlaxoSmithKline PLC in connection with the acquisition of Novartis’ global vaccines business (excluding influenza vaccines), creating a new world-leading joint venture with Novartis and divesture of GSK’s Oncology business to Novartis.